AI CuratorAI-generated
Research summary · AI summary · not yet reviewedAnimal studyPreclinicalPeer-reviewed
Mouse Study on Fingolimod's Effects in EAE Model
In a mouse model of multiple sclerosis using EAE, fingolimod treatment led to significant improvements in MRI parameters associated with spinal cord pathology and clinical paralysis after 28 days, outperforming vehicle controls. The study showed that MRI metrics could predict up to 87.2% of variance in pathology and 80.1% in paralysis.
- Tags
- #Other
- Most relevant to
- —
This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.
Why it matters
This research enhances understanding of non-invasive biomarkers for evaluating multiple sclerosis therapies and could refine therapeutic assessment methods.
What this does not prove
Results are based on animal models, limiting direct applicability to human MS. The sensitivity and specificity for clinical practice remain untested.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Observational
- Participants / samples
- Not reported
- Randomised
- Yes
- Controlled
- Yes
- Primary endpoint met
- Yes
- Relevant MS type
- Not reported
- Publication date
- 2026-09-17
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Other
Original sources
- Primary evidenceCross-modality network phenotyping: a multivariate MRI biomarker signature predicts spatial pathology and clinical severity in EAE. ↗DOI: 10.3389/fneur.2026.1850801
Supporting passages (16)
study phaseEAE was induced in mice using a myelin oligodendrocyte glycoprotein peptide, followed by treatment with either vehicle or fingolimod.
study designTo address this, we developed an automated, spatially targeted multiparametric magnetic resonance imaging (MRI) pipeline to extract highly specific in vivo biophysical markers and benchmarked its performance against a potent positive control immunomodulator, fingolimod.
subjectsEvaluating novel therapies for multiple sclerosis requires robust, non-invasive biomarkers.
speciesIn the experimental autoimmune encephalomyelitis (EAE) model, standard disease evaluations rely heavily on subjective clinical motor scoring and terminal histology, which frequently suffer from a mathematical dilution effect.
randomizedRESULTS: Vehicle-treated mice exhibited severe elevations in gray matter T2 relaxation times and precipitous drops in white matter fractional anisotropy, structurally mapping to localized edema, demyelination, and dense cellular infiltrates.
controlledFingolimod treatment successfully rescued these structural deficits, alongside clinical motor deficits and T-cell infiltration.
peer reviewedJournal: Frontiers in neurology
primary endpoint metMultivariate predictive modeling showed that the combined MRI panel predicted up to 87.2% of the variance in regional spinal cord pathology and 80.1% of the variance in clinical paralysis.
research categoriesBy overcoming the dilution effect, this non-invasive approach provides an objective, continuous metric that complements traditional tissue assays, enhancing the evaluation of multiple sclerosis therapeutics while advancing the reduction of animal use.
publication datePublication date: 2026-09-17
interventionMETHODS: EAE was induced in mice using a myelin oligodendrocyte glycoprotein peptide, followed by treatment with either vehicle or fingolimod.
comparatorRESULTS: Vehicle-treated mice exhibited severe elevations in gray matter T2 relaxation times and precipitous drops in white matter fractional anisotropy, structurally mapping to localized edema, demyelination, and dense cellular infiltrates.
primary endpointFingolimod treatment successfully rescued these structural deficits, alongside clinical motor deficits and T-cell infiltration.
follow upAt 28 days post-induction, in vivo T2-weighted and diffusion tensor imaging maps of the lumbar spinal cord were acquired and segmented into specific gray and white matter columns.
findingsMultivariate predictive modeling showed that the combined MRI panel predicted up to 87.2% of the variance in regional spinal cord pathology and 80.1% of the variance in clinical paralysis.
limitationsTitle: Cross-modality network phenotyping: a multivariate MRI biomarker signature predicts spatial pathology and clinical severity in EAE.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.